AZ-TAK1
Product Specifications
CAS Number
1413440-36-4
Target
MAPK|||Others
Related Pathways
Others|||MAPK
Bioactivity
AZ-Tak1 is a potent and a relatively selective inhibitor of TAK1 kinase activity, with an IC50 of 0.009 mM. AZ-Tak1 treatment decreased the level of p38 and ERK in mantle cell lymphoma cells, and induced apoptosis in a dose and time dependent manner, with an IC50 of 0.1–0.5 mM. Using the annexin-V and PI staining and FACS analysis, After 48 hours of incubation, AZ-Tak1 (0.1 mM) induced apoptosis in 28%, 34% and 86% of Mino, SP53, and Jeko cells, respectively, which was increased to 32%, 42%, and 86% when 0.5 mM concentration was used.
Smiles
FC=1C(C=2N3C(=NC2)C=CC=N3)=NC(NC4=CC(OCCN5CCC(O)CC5)=CC(CC)=C4)=NC1
Molecular Formula
C25H28FN7O2
Molecular Weight
477.53
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6386489-01 0.1 mL
NAPSA (NAP1, NAPA, Napsin-A, Aspartyl Protease 4, ASP4, Asp 4, Napsin-1, TA01/TA02) (PE)
Ask
View Details 
MBS6386489-02 5x 0.1 mL
NAPSA (NAP1, NAPA, Napsin-A, Aspartyl Protease 4, ASP4, Asp 4, Napsin-1, TA01/TA02) (PE)
Ask
View Details 
GTR15378233 1 Vial
Lentiviral human NBPF12 sgRNA gene knockout kit - Lentiviral human NBPF12 sgRNA gene knockout kit (plasmid)
Ask
View Details